ROTY Recap: 5 Biotech Runners From The Previous Week

I'm expecting a positive data readout for InflaRx's phase 2b study evaluating IFX-1 in patients with moderate or severe Hidradenitis Suppurativa.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *